other material
confidence high
sentiment positive
materiality 0.70
Pasithea completes tender offer: buys 5.32M shares at $0.70; post-offer shares 20.8M
Pasithea Therapeutics Corp.
- All 5,323,451 validly tendered shares accepted for purchase at $0.70 per share, no proration.
- Tender offer expired Sept 8, 2023; funded from cash on hand.
- Post-offer shares outstanding: 20,819,956; CEO notes >8.5M shares repurchased over past 9 months.
- CEO: low tender indicates shareholder confidence; buyback provides liquidity and increases remaining holders' ownership.